Galderma Group Ag (GDERF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you, operator. Warm welcome to GoDerma's full year 2025 financial results webcast. The press release along with GoDerma's 2025 annual reports were published today at 7 a.m. Central European Standard Time and can be consulted on our corporate website at any time. Today's presentation slides as well as a recording of this webcast will be made available on our website after the call. Please be advised that today's presentation contains forward-looking statements, which should be treated with the appropriate level of caution as detailed on this slide. Let me now introduce today's full-year financial results webcast. Dr. Fleming-Ortkov, the CEO of Goderma, and Thomas Dietrich, CFO, will provide a performance update and discuss the financial results for the full year, followed by the outlook for both 26 and the midterm. After the presentation, both Fleming and Thomas will be available to answer questions from the financial analysts before Flemming provides his final remarks to close the webcast. With this, I'd like to invite Flemming to start with Golderma's highlights for 2025. Flemming, over to you. Thank you, Emil. Good morning, good afternoon, and welcome to Golderma's full year 2025 financial results webcast. It's an honor to be here today and to confirm yet another record performance for the companies. 2025 was a year of opportunities, and thanks to our team's hard work, we made important progress towards our ambition of becoming the undisputed dermatology powerhouse. We now have a robust foundation to continue driving very attractive top and bottom line growth in 2026. Our journey as a dermatology category leader did not start in 2025, but six years ago with a transformation guided by our growth-focused integrated dermatology strategy. In 2020, we started our ...